All In Biotech

Drug Trial Radar · NCT01368588

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

Last checked: Nov 20, 2026Latest source record: May 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,590 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

2,590

Actual

Start

Jul 2011

Primary completion

Apr 17, 2025

Study completion Jul 2031

Sponsor

Lead sponsor
Radiation Therapy Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); NRG Oncology
First posted
Jun 8, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to kill tumor cells. PURPOSE: This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer.

Conditions

  • Prostate Cancer

Interventions

  • three-dimensional conformal radiotherapyRadiation

    Daily fractions

  • intensity modulated radiotherapyRadiation

    Daily fractions

  • BrachytherapyRadiation

    Implant

  • Anti-androgenDrug

    Tablet

  • luteinizing hormone-releasing hormone (LHRH) agonist or antagonistDrug

    Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Alive (Overall Survival)Time frame: From randomization to death or last follow-up. Median follow-up at time of analysis was 6.8 years. Five- and ten-year estimates are reported.

Locations

478 sites in 6 countries. Site status is shown where the registry gives one.

  • University of South Alabama Mitchell Cancer Institute

    Mobile, Alabama

  • Anchorage Associates in Radiation Medicine

    Anchorage, Alaska

  • Alaska Oncology and Hematology LLC

    Anchorage, Alaska

  • Anchorage Oncology Centre

    Anchorage, Alaska

  • Katmai Oncology Group

    Anchorage, Alaska

  • Providence Alaska Medical Center

    Anchorage, Alaska

  • Fairbanks Memorial Hospital

    Fairbanks, Alaska

  • Arizona Breast Cancer Specialists-Gilbert

    Gilbert, Arizona

  • Arizona Center for Cancer Care-Peoria

    Peoria, Arizona

  • Cancer Center at Saint Joseph's

    Phoenix, Arizona

  • Saint Joseph's Hospital and Medical Center

    Phoenix, Arizona

  • Arizona Breast Cancer Specialists-Phoenix

    Phoenix, Arizona

  • Arizona Oncology-Deer Valley Center

    Phoenix, Arizona

  • 21st Century Oncology-Scottsdale

    Scottsdale, Arizona

  • Arizona Breast Cancer Specialists

    Scottsdale, Arizona

  • Arizona Breast Cancer Specialists-Scottsdale

    Scottsdale, Arizona

  • Arizona Oncology Services Foundation

    Scottsdale, Arizona

  • Arizona Center for Cancer Care-Surprise

    Surprise, Arizona

  • Arizona Oncology Associates-West Orange Grove

    Tucson, Arizona

  • University of Arizona Cancer Center-Orange Grove Campus

    Tucson, Arizona

  • Banner University Medical Center - Tucson

    Tucson, Arizona

  • University of Arizona Cancer Center-North Campus

    Tucson, Arizona

  • CHI Saint Vincent Cancer Center Hot Springs

    Hot Springs, Arkansas

  • Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

    Jonesboro, Arkansas

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Sutter Cancer Centers Radiation Oncology Services-Auburn

    Auburn, California

  • AIS Cancer Center at San Joaquin Community Hospital

    Bakersfield, California

  • Alta Bates Summit Medical Center-Herrick Campus

    Berkeley, California

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California

  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park

    Cameron Park, California

  • Mercy San Juan Medical Center

    Carmichael, California

  • Adventist Health Cancer Care Center Chico

    Chico, California

  • Fresno Cancer Center

    Fresno, California

  • Saint Agnes Medical Center

    Fresno, California

  • Marin General Hospital

    Greenbrae, California

  • UC San Diego Moores Cancer Center

    La Jolla, California

  • Tibor Rubin VA Medical Center

    Long Beach, California

  • Los Angeles County-USC Medical Center

    Los Angeles, California

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California

  • Cedars Sinai Medical Center

    Los Angeles, California

Showing 40 of 478 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.